Calcium aluminium silicate - Salient Pharmaceuticals

Drug Profile

Calcium aluminium silicate - Salient Pharmaceuticals

Alternative Names: Aluminium calcium silicate; Aluminum calcium silicate; Calcium alumina-silicate; Calcium aluminosilicate; Calcium aluminosilicate anti-diarrheal; Calcium aluminosilicate anti-diarrhoeal - Salient Pharmaceuticals; Calcium aluminum silicate; Calcium silicoaluminate; CASAD; Silicate cement; Silicic acid aluminium calcium salt; Silicic acid aluminum calcium salt

Latest Information Update: 19 Apr 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Salient Pharmaceuticals
  • Developer Salient Pharmaceuticals; University of Texas M. D. Anderson Cancer Center
  • Class Aluminium compounds; Antidiarrhoeals; Calcium compounds; Noncarboxylic acids
  • Mechanism of Action Cytokine inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Clostridium-difficile-infections; Diarrhoea; Inflammatory bowel diseases; Proctitis; Stomatitis

Most Recent Events

  • 19 Apr 2016 No recent reports on development identified - Phase-II for Diarrhoea (Chemotherapy-induced) in USA (PO)
  • 19 Apr 2016 No recent reports on development identified - Preclinical for Clostridium difficile infections in USA (PO)
  • 19 Apr 2016 No recent reports on development identified - Preclinical for Inflammatory bowel disease in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top